![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](ci2939contents.gif)
Acta Cryst. (2009). E65, m1399-m1400 [ doi:10.1107/S160053680904241X ]
O1)(isonicotinamide-
N1)zinc(II)]-
-4-formylbenzoato-
2O1:O1']Abstract: In the title compound, [Zn(C8H5O3)2(C6H6N2O)]n, the ZnII ion is tetrahedrally coordinated by two formylbenzoate (FB) and one isonicotinamide (INA) ligands while symmetry-related FB ligands bridge adjacent ZnII ions, forming polymeric chains along the b axis. The carboxylate groups in the two FB ions are twisted away from the attached benzene ring by 9.07 (2) and 26.2 (2)°. The two benzene rings of the FB ions are oriented at a dihedral angle of 81.30 (5)°. In the crystal, adjacent polymeric chains interact via N-H
O and C-H
O hydrogen bonds,
-
contacts between the formylbenzoate rings [centroid-centroid distance = 3.7736 (8) Å] and weak C-H
interactions, forming a three-dimensional network.
Online 23 October 2009
Copyright © International Union of Crystallography
IUCr Webmaster